Literature DB >> 15911782

Implications of multimechanism therapy: when to treat?

Rami Burstein1, Moshe Jakubowski.   

Abstract

Mesh:

Year:  2005        PMID: 15911782     DOI: 10.1212/wnl.64.10_suppl_2.s16

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.

Authors:  Arsalan U Syed; Masayo Koide; Karen M Braas; Victor May; George C Wellman
Journal:  J Mol Neurosci       Date:  2012-07-06       Impact factor: 3.444

Review 2.  Insights from experimental studies into allodynia and its treatment.

Authors:  Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2006-06

3.  Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients.

Authors:  Anna Ferrari; Diego Pinetti; Alfio Bertolini; Ciro Coccia; Emilio Sternieri
Journal:  Eur J Clin Pharmacol       Date:  2008-01-08       Impact factor: 2.953

4.  Scalp periarterial saline efficacy in migraine and relation to exploding and imploding headache.

Authors:  Carlo Cianchetti; Yousef Hmaidan; Gabriele Finco; Maria Giuseppina Ledda
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

5.  Acute migraine: Current treatment and emerging therapies.

Authors:  Arun A Kalra; Debra Elliott
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.